2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: What is new?

Öngen, Zeki

Journal Metrics

Impact Factor (2024): 0.9
CiteScore (2023): 1.3
Source Normalized Impact
per Paper:
0.315
SCImago Journal Rank: 0.250

52/8Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and

In titles and abstracts

In keywords

In all

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: What is new? [Turk Kardiyol Dern Ars]

Turk Kardiyol Dern Ars. 2018; 46(1): 1-6 | DOI: 10.5543/tkda.2017.77775

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: What is new?

Zeki Öngen
Department of Cardiology, İstanbul University Cerrahpaşa Faculty and Medicine, İstanbul, Turkey

Keywords: aspirin, P2Y12 inhibitors, antiplatelet, antithombotic, percutaneous coronary intervention

Corresponding Author: Zeki Öngen, Türkiye
Manuscript Language: Turkish

CITE

Full Text PDF Download citation RIS EndNote BibTex Medlars Procite Reference Manager Send email to author Similar articles PubMed Google Scholar